Mettler-Toledo (MTD) | Financial Analysis & Statements
Mettler-Toledo International Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.1B
Gross Profit
675.4M
59.79%
Operating Income
343.3M
30.39%
Net Income
285.8M
25.29%
EPS (Diluted)
$13.98
Balance Sheet Metrics
Total Assets
3.7B
Total Liabilities
3.7B
Shareholders Equity
-23.6M
Cash Flow Metrics
Operating Cash Flow
276.1M
Free Cash Flow
184.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Mettler-Toledo Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.0B | 3.9B | 3.8B | 3.9B | 3.7B |
| Cost of Goods Sold | 1.6B | 1.5B | 1.5B | 1.6B | 1.5B |
| Gross Profit | 2.4B | 2.3B | 2.2B | 2.3B | 2.2B |
| Gross Margin % | 59.4% | 60.1% | 59.2% | 58.9% | 58.4% |
| Operating Expenses | |||||
| Research & Development | 199.4M | 189.4M | 185.3M | 177.1M | 169.8M |
| Selling, General & Administrative | 998.3M | 936.3M | 904.1M | 938.5M | 944.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.2B | 1.1B | 1.1B | 1.1B | 1.1B |
| Operating Income | 1.1B | 1.1B | 1.1B | 1.1B | 994.7M |
| Operating Margin % | 27.8% | 29.1% | 28.5% | 28.7% | 26.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 68.5M | 74.6M | 77.4M | 55.4M | 43.2M |
| Other Non-Operating Income | -1.1M | -15.2M | -28.6M | -236.0K | -2.1M |
| Pre-tax Income | 1.0B | 1.0B | 973.7M | 1.1B | 949.4M |
| Income Tax | 179.7M | 174.1M | 185.0M | 198.1M | 180.4M |
| Effective Tax Rate % | 17.1% | 16.8% | 19.0% | 18.5% | 19.0% |
| Net Income | 869.2M | 863.1M | 788.8M | 872.5M | 769.0M |
| Net Margin % | 21.6% | 22.3% | 20.8% | 22.3% | 20.7% |
| Key Metrics | |||||
| EBITDA | 1.3B | 1.3B | 1.2B | 1.2B | 1.1B |
| EPS (Basic) | $42.17 | $40.67 | $36.10 | $38.79 | $33.25 |
| EPS (Diluted) | $42.05 | $40.48 | $35.90 | $38.41 | $32.78 |
| Basic Shares Outstanding | 20610189 | 21221839 | 21848122 | 22491790 | 23129862 |
| Diluted Shares Outstanding | 20610189 | 21221839 | 21848122 | 22491790 | 23129862 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Mettler-Toledo Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 66.9M | 59.4M | 69.8M | 96.0M | 98.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 778.2M | 687.1M | 663.9M | 709.3M | 647.3M |
| Inventory | 387.2M | 342.3M | 385.9M | 441.7M | 414.5M |
| Other Current Assets | 130.3M | 105.2M | 110.6M | 128.1M | 108.9M |
| Total Current Assets | 1.4B | 1.2B | 1.2B | 1.4B | 1.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 1.8B | 1.6B | 1.6B | 1.6B | 1.6B |
| Intangible Assets | 278.9M | 257.1M | 285.4M | 306.1M | 307.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 486.2M | 349.8M | 366.4M | 372.5M | 302.0M |
| Total Non-Current Assets | 2.3B | 2.0B | 2.1B | 2.1B | 2.1B |
| Total Assets | 3.7B | 3.2B | 3.4B | 3.5B | 3.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 266.6M | 215.8M | 210.4M | 252.5M | 272.9M |
| Short-term Debt | 63.9M | 182.6M | 192.2M | 106.1M | 101.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 1.2B | 1.2B | 1.2B | 1.1B | 1.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.1B | 1.8B | 1.9B | 1.9B | 1.6B |
| Deferred Tax Liabilities | 151.8M | 104.0M | 108.7M | 111.4M | 62.2M |
| Other Non-Current Liabilities | 298.1M | 263.5M | 327.1M | 300.0M | 365.8M |
| Total Non-Current Liabilities | 2.5B | 2.2B | 2.3B | 2.3B | 2.0B |
| Total Liabilities | 3.7B | 3.4B | 3.5B | 3.5B | 3.2B |
| Equity | |||||
| Common Stock | 448.0K | 448.0K | 448.0K | 448.0K | 448.0K |
| Retained Earnings | 9.2B | 8.4B | 7.5B | 6.7B | 5.9B |
| Treasury Stock | 9.8B | 9.0B | 8.2B | 7.3B | 6.3B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -23.6M | -126.9M | -149.9M | 24.8M | 171.4M |
| Key Metrics | |||||
| Total Debt | 2.2B | 2.0B | 2.1B | 2.0B | 1.7B |
| Working Capital | 164.6M | 25.7M | 49.1M | 227.4M | 122.8M |
Balance Sheet Composition
Mettler-Toledo Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 869.2M | 863.1M | 788.8M | 872.5M | 769.0M |
| Depreciation & Amortization | 125.6M | 123.2M | 121.2M | 113.0M | 108.1M |
| Stock-Based Compensation | 22.5M | 20.0M | 17.9M | 19.7M | 19.6M |
| Working Capital Changes | -31.1M | -17.8M | 101.4M | -156.9M | -96.3M |
| Operating Cash Flow | 990.0M | 960.3M | 1.0B | 874.8M | 808.2M |
| Investing Activities | |||||
| Capital Expenditures | -107.1M | -102.3M | -104.5M | -120.8M | -103.9M |
| Acquisitions | -93.8M | -10.1M | -5.8M | -38.0M | -220.9M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -193.9M | -119.5M | -131.7M | -139.4M | -314.1M |
| Financing Activities | |||||
| Share Repurchases | -800.0M | -850.0M | -900.0M | -1.1B | -1,000.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 2.0B | 2.2B | 2.1B | 2.3B | 2.4B |
| Debt Repayment | -2.0B | -2.2B | -2.1B | -1.9B | -2.0B |
| Financing Cash Flow | -787.4M | -879.7M | -878.8M | -2.7B | -2.6B |
| Free Cash Flow | 848.6M | 864.4M | 860.6M | 737.8M | 801.2M |
| Net Change in Cash | 8.7M | -38.8M | 5.4M | -2.0B | -2.2B |
Cash Flow Trend
Mettler-Toledo Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.07
Forward P/E
24.70
Price to Book
-1,090.80
Price to Sales
6.36
PEG Ratio
1.79
Profitability Ratios
Profit Margin
21.59%
Operating Margin
30.71%
Return on Equity
-3,677.41%
Return on Assets
20.35%
Financial Health
Current Ratio
1.14
Debt to Equity
-95.84
Beta
1.44
Per Share Data
EPS (TTM)
$42.05
Book Value per Share
$-1.16
Revenue per Share
$195.36
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MTD | 25.6B | 30.07 | -1,090.80 | -3,677.41% | 21.59% | -95.84 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Idexx Laboratories | 44.7B | 42.92 | 27.85 | 66.20% | 24.62% | 60.83 |
| Agilent Technologies | 32.7B | 25.67 | 4.76 | 19.95% | 18.26% | 51.39 |
| Waters | 30.5B | 28.90 | 7.24 | 29.28% | 20.30% | 60.28 |
Financial data is updated regularly. All figures are in the company's reporting currency.






